The move comes as the government keeps regular recruitment rules for the post in abeyance, signaling a preference for leadership continuity within the Central Drugs Standard Control Organization ...

Bengaluru: Gilead Sciences will pay as much as USD 7.8 billion to acquire partner Arcellx in its largest deal since 2020, the biopharma company said on Monday, as it looks to strengthen its ...

The Indian Pharmacopoeia Commission (IPC), in its latest Drug Safety Alert has flagged safety signals indicating that the ...

It is sugar-rush economics, looking for a quick fix with no regard to the longer-term consequences. And of course it has a cost, threatening to boost inflation, damage confidence in US assets and lead ...